drugset / Trial / NCT00175604

Comparative Trial of Botox in the Management of Children With Congenital Muscular Torticollis

NCT00175604

Phase 1 Withdrawn University of British Columbia
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The primary purpose is to investigate the effect of Botox on the treatment of congenital muscular torticollis (CMT). The investigators' hypothesis is that a Botox injection will be an effective treatment when used in conjunction with current treatment procedures.

Timeline

Start
2004-08
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic

Indications

No indication recorded.